Harwell’s HealthTec cluster celebrates 5th year anniversary with new strategy

Harwell Campus marked the 5th anniversary of its HealthTec Cluster on 23rd July, with a hybrid conference. Speakers, panelists and guests joined a small group of attendees for a first face to face event, hosted by the Rosalind Franklin Institute. Business Minister and Minister for Covid Vaccine Deployment, Nadhim Zahawi, MP, gave a keynote address to the conference.  Regius Professor of Medicine at University of Oxford, Professor Sir John Bell, followed, with both reflecting on the power of collaboration and the value of clusters such as Harwell in addressing the pandemic.

To watch the event: click here

New Strategy for the cluster

Cluster manager, Dr Adrian Hill, gave an overview of the refreshed strategy for the cluster, which aims to grow to at least 100 life sciences and healthtec companies over ten years, generating more than 5,000 jobs.  The campus is also planning for 750 thousand square feet of new specialist accommodation for the life sciences sector on site.  Building on the campus’s strengths and scientific infrastructure, there will be a particular focus on vaccines research and development, next generation imaging, diagnostics and advanced therapies.  Harwell-HealthTec-Cluster-Strategy-2021-2031

.Barbara Ghinelli of STFC opens the HealthTec conference

Images above taken from the conference – industry panel discussion, chaired by Prof Sir John Bell; Oxford Nanopore, SiHealth and The Electrospinning Company were among the companies, based within the HealthTec Campus, that participated in the event and exhibition.

Recent news

Times Higher Education article – female academic founders

Times Higher Education article – female academic founders

Advanced Oxford member and collaborator considers the role of investors in supporting female academic founders Simonetta Manfredi is a professor of equality and diversity management, and the Director for Research, Innovation and Enterprise at Oxford Brookes...

read more
Amano Enzyme establishes new European hub at Milton Park

Amano Enzyme establishes new European hub at Milton Park

The world’s leading manufacturer of speciality enzymes, has established its new Europe, Middle East and Africa (EMEA) hub at Milton Park. Amano Enzymes, the Japanese biotechnology company - which uses its enzymes to boost the flavour, texture, colour, digestion and...

read more
Next step in expansion of The Oxford Science Park

Next step in expansion of The Oxford Science Park

Detailed planning application submitted for Plot 27 New R&D building part of >500,000 sq ft expansion plan as the Park innovation ecosystem grows. The Oxford Science Park (TOSP), one of Europe’s leading locations for science and technology companies, is...

read more
Loading...